Kathleen Wijnant

Mrs. Kathleen Wijnant

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in Talanta
Verified
Journal Article
Closed access
LMLieven Van Meulebroek
Lieven Van Meulebroek
SCSimon Cameron
Simon Cameron
VPVera Plekhova
Vera Plekhova
MSMargot De Spiegeleer
Margot De Spiegeleer
KWKathleen Wijnant
Kathleen Wijnant
LVLynn Vanhaecke
Lynn Vanhaecke

19 October 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
KWKathleen Wijnant
Kathleen Wijnant
JKJoanna Klosowska
Joanna Klosowska
CBCaroline Braet
Caroline Braet
SVSandra Verbeken
Sandra Verbeken
SDStefaan DeHenauw
Stefaan DeHenauw
NMNathalie Michels
Nathalie Michels
The persistent coexistence of stress and paediatric obesity involves interrelated psychophysiological mechanisms, which are believed to function as a vicious circle. Here, a key mechanistic role is assumed for stress responsiveness and eating behaviour. After a stress induction by the Trier Social Stress Test in youngsters (n = 137, 50.4% boys, 6–18 years), specifically those high in chronic stress level and overweight (partial η2 = 0.03–0.07) exhibited increased stress vulnerability (stronger relative salivary cortisol reactivity and weaker happiness recovery) and higher fat/sweet snack intake, compared to the normal-weight and low-stress reference group. Stress responsiveness seems to stimulate unhealthy and emotional eating, i.e., strong cortisol reactivity was linked to higher fat/sweet snack intake (β = 0.22) and weak autonomic system recovery was linked to high total and fat/sweet snack intake (β = 0.2–0.3). Additionally, stress responsiveness acted as a moderator. As a result, stress responsiveness and emotional eating might be targets to prevent stress-induced overweight.

9 June 2023 in Science Advances
Verified
Journal Article
Open access
MSMargot De Spiegeleer
Margot De Spiegeleer
VPVera Plekhova
Vera Plekhova
JGJozefien Geltmeyer
Jozefien Geltmeyer
ESElla Schoolaert
Ella Schoolaert
BPBeata Pomian
Beata Pomian
LVLynn Vanhaecke
Lynn Vanhaecke
In recent years, ambient ionization mass spectrometry (AIMS) including laser ablation rapid evaporation IMS, has enabled direct biofluid metabolome analysis. AIMS procedures are, however, still hampered by both analytical, i.e., matrix effects, and practical, i.e., sample transport stability, drawbacks that impede metabolome coverage. In this study, we aimed at developing biofluid-specific metabolome sampling membranes (MetaSAMPs) that offer a directly applicable and stabilizing substrate for AIMS. Customized rectal, salivary, and urinary MetaSAMPs consisting of electrospun (nano)fibrous membranes of blended hydrophilic (polyvinylpyrrolidone and polyacrylonitrile) and lipophilic (polystyrene) polymers supported metabolite absorption, adsorption, and desorption. Moreover, MetaSAMP demonstrated superior metabolome coverage and transport stability compared to crude biofluid analysis and was successfully validated in two pediatric cohorts (MetaBEAse, n = 234 and OPERA, n = 101). By integrating anthropometric and (patho)physiological with MetaSAMP-AIMS metabolome data, we obtained substantial weight-driven predictions and clinical correlations. In conclusion, MetaSAMP holds great clinical application potential for on-the-spot metabolic health stratification.


24 April 2023 in ChemRxiv
Verified
Preprint
Open access
PDF file
MSMargot De Spiegeleer
Margot De Spiegeleer
VPVera Plekhova
Vera Plekhova
JGJozefien Geltmeyer
Jozefien Geltmeyer
ESElla Schoolaert
Ella Schoolaert
BPBeata Pomian
Beata Pomian
LVLynn Vanhaecke
Lynn Vanhaecke
While rapid analysis of the human biofluid metabolome is now possible using ambient ionization mass spectrometry (AIMS), these procedures are hampered by in-source matrix effects and reduced sample stability impeding metabolome coverage while remaining relatively labor-intensive. In this study, we aimed at developing biofluid-specific metabolome sampling membranes (MetaSAMP®s, WO2021/191467) that offer a directly applicable and stabilizing substrate for AIMS. Customized rectal, salivary and urinary MetaSAMP®s consisting of multilayered electrospun nanofibrous membranes of blended hydrophilic (polyvinylpyrrolidone and polyacrylonitrile) and lipophilic (polystyrene) polymers supported adequate metabolite ab- , ad-, and desorption. Moreover, MetaSAMP® demonstrated superior metabolome coverage and transport stability compared to crude biofluid analysis and was successfully validated in two pediatric cohorts (MetaBEAse, n=234, feces and urine; OPERA, n=138, saliva). By integrating anthropometric and (patho)physiological with MetaSAMP®-AIMS metabolome data, we obtained significant weight-driven predictions and clinical correlations. In conclusion, MetaSAMP® holds great clinical application potential for on-the-spot metabolic health stratification.